Examples of 'moderate to severe hepatic' in a sentence
Meaning of "moderate to severe hepatic"
moderate to severe hepatic - This phrase indicates the range of liver conditions spanning from moderate to severe. It is commonly used in medical contexts to describe the severity of liver issues
How to use "moderate to severe hepatic" in a sentence
Basic
Advanced
moderate to severe hepatic
Patients with moderate to severe hepatic impairment.
Plasma clearance of topiramate is decreased in patients with moderate to severe hepatic impairment.
Moderate to severe hepatic impairment.
No data are available in patients with moderate to severe hepatic impairment.
Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine HCl substantially.
Delamanid is not recommended in patients with moderate to severe hepatic impairment.
Patients with moderate to severe hepatic impairment may have increased exposure see section 5.2.
There are no data available for patients with moderate to severe hepatic impairment.
If patients progress from moderate to severe hepatic impairment safinamide should be stopped ( see section 4.4 ).
No pharmacokinetic data are available for quetiapine in patients with moderate to severe hepatic impairment.
If patients progress from moderate to severe hepatic impairment Xadago should be stopped see section 4.4.
There are only very limited data available in patients with moderate to severe hepatic impairment.
Patients with moderate to severe hepatic impairment ( Child-Pugh B and C ) due to risk of potential toxicity.
The use of EVOTAZ is contraindicated in patients with moderate to severe hepatic impairment.
Ceritinib is not recommended in patients with moderate to severe hepatic impairment see section 5.2.
See also
Triumeq is not recommended in patients with moderate to severe hepatic impairment see section 4.2.
EVOTAZ must not be used in patients with moderate to severe hepatic impairment see section 4.3.
Caution is advised in patients with moderate to severe hepatic impairment ( see section 4.4 ).
Delamanid is not recommended in patients with moderate to severe hepatic impairment see sections 4.4 and 5.2.
Deltyba is not recommended in patients with moderate to severe hepatic impairment see sections 4.2 and 5.2.
Therefore, lorlatinib is not recommended in patients with moderate to severe hepatic impairment ( see section 5.2 ).
Ceritinib is not recommended for patients with moderate to severe hepatic impairment see sections 4.2 and 4.8.
You'll also be interested in:
Examples of using Hepatic
Show more
Progressive renal or hepatic end organ dysfunction
Hepatic toxicity has been associated with acetaminophen
Monitoring of the hepatic function is also recommended
Examples of using Severe
Show more
This place has a severe tonal problem
Severe thermal burns can occur on contact
There are mild and severe cases of frostbite
Examples of using Moderate
Show more
There are moderate to large amounts of ketones in urine
Most undesirable effects were mild to moderate in severity
Exert only moderate pressure on the workpi
